The European Summit for Clinical Nanomedicine and Targeted Medicine has become one of the globally most relevant events with an exciting bouquet of the advances and possibilities of Nanomedicine on international level. The summit will provide a cutting-edge cross section highlighting the importance and progress of nanotechnology in the evolution of the medicine of tomorrow. Substantially improved diagnosis and therapy, enabled by nanomedicine, will be the corner stones for the personalized medicine of tomorrow.
From June 22 to 25 CLINAM 7/2014 in Basel offers the unique opportunity to meet internationally renowned experts from all fields of the highly interdisciplinary nanomedical community: researchers from medicine, nanotechnology, biology, physics, chemistry, biotechnology and pharmacy as well as key actors from small and medium enterprises and from large established pharmaceutical companies. For the first time CINAM will unite in its annual regulatory authorities plenary session representatives from agencies responsible for approval of drugs and devices from all continents (Europe, America, Asia, Africa, Australia and India). In this unique session, ample time is provided, allowing to direct questions to the representatives and to discuss support and obstacles in approval processes.
The CLINAM/ETPN Summit is now the international landmark in the field of Nanomedicine and Targeted Medicine. CLINAM and the ETPN are together the largest European Interest Group to develop nanomedicine for the benefit of the patient. For industry, research and policy this meeting has become an indispensable platform.
CLINAM 7/2014 will again offer an excellent platform to all participants for new contacts and network-building. The previous CLINAM conferences led numerous new European and international cooperation. Since the first Summit in 2008 eight companies were created, a large number of EU Framework applications became successful projects as, for example, Nanomded2020, DiscoGnosis, and NanoAthero, of which the latter is also introduced in this special issue on Cardiovascular Nanomedicine of the European Journal of Nanomedicine. A further 16 cooperation projects on national and international level had their cradle at one of the previous CLINAM-Summits in Basel.
This year, it is the spot, where you find more than 150 presentations from internationally recognized experts in the fields -short, precise, to the point -and ample chances to discuss the topic in depth in small groups with the speakers. CLINAM enables in the era of fastest information-flow ever to choose presentations related to the own focus field and discuss in depth what catches the interest most. The summit has become the brokerage place for international relations between the experts. 
